Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
Clinical trial NCT04908475 · COMPLETED
Trial details
- NCT number
- NCT04908475
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2023-04-20
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.